• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home Uncategorized

Childhood ADHD associated with increased risk of suicide [Physician Comment]

bys25qthea
March 6, 2013
in Uncategorized
Reading Time: 4 mins read
Childhood ADHD associated with increased risk of suicide [Physician Comment]
Share on FacebookShare on TwitterShare on LinkedIn

[tabs tab1=”2MM Rundown” tab2= “2MM Full Report”]

[tab]

Image: PD

1. There is an association between having childhood ADHD and having additional psychiatric disorders later in life (P <0.01).  

2. There is an association between childhood ADHD and suicide (P = 0.032).  

This prospective study of long-term adult outcomes of childhood ADHD found that childhood ADHD might affect the risk of suicide and that it increases the risk of developing additional psychiatric disorders in later life, especially if ADHD persists. This is the first long term study of its kind.

RELATED REPORTS

Second-stage cesarean and operative vaginal deliveries are associated with similar neurodevelopmental outcomes in children

Tylenol in the Spotlight: Pregnancy, Autism, and Evolving Guidance on Acetaminophen use

This implies that the treatment of childhood ADHD could have an important impact on later outcomes. Previous research from this group has shown that treatment of childhood ADHD can improve a number of outcomes through the age of 19. Forthcoming research should shed light on the impact of treatment on adult outcomes.

It remains to be clarified whether there is some underlying mechanism that predisposes individuals both to ADHD and other psychiatric disorders, or whether ADHD itself promotes the development of other psychiatric disorders (or both). If the latter is true, proper treatment of childhood ADHD should reduce the likelihood of developing additional psychiatric disorders.

The study population was relatively homogenous in terms of race and socioeconomic status, which limits the generalizability of the study. However, one might predict worse outcomes in settings of poverty and lack of access to treatment.

Click to read the study in Pediatrics

[/tab]

[tab]

Image: PD

1. There is an association between having childhood ADHD and having additional psychiatric disorders later in life (P <0.01). 

2. There is an association between childhood ADHD and suicide (P = 0.032).  

Dr. William Barbaresi, M.D., talks to 2 Minute Medicine: Associate Chief, Division of Developmental Medicine, Boston Children’s Hospital; Associate Professor of Pediatrics, Harvard Medical School

7701379“The findings presented in Pediatrics represent the first, high level report of adult outcomes for our cohort of childhood ADHD cases.  We have collected an extensive set of data, including information about childhood treatment.  In forthcoming manuscripts, we will be addressing the issue of treatment and its association with a variety of outcomes.

It is very important to recognize that the long-term impact of childhood ADHD is related not just to the persistence of ADHD into adulthood, but also includes the significant risk for other adult mental health problems, as we reported in this paper… The long-term impact of childhood ADHD includes essentially every aspect of adult life, including education, employment, income, relationships, risk-taking behavior, etc.”

This [prospective] study: Individuals born between 1976 and 1982 in a district of Rochester, MN who gave consent were eligible for the study. Cases of childhood ADHD were identified retrospectively using a multi-step process drawing on school and medical records. 367 individuals with childhood ADHD from this cohort were enrolled in the prospective arm of the study.

There were 3 suicides in the childhood ADHD cohort, and 5 suicides in the rest of the birth cohort (n = 4946) through 2009. There is a weakly significant association between childhood ADHD and suicide (P = 0.032).

57% of the individuals with childhood ADHD had one or more psychiatric disorders as adults, compared to 34.9% of the prospectively followed controls (n = 801, P <0.01). The association is even stronger for those whose ADHD persists into adulthood compared to those whose ADHD did not persist (80.9% vs. 47.0%; P < 0.001).

In sum: This prospective study of long-term adult outcomes of childhood ADHD found that childhood ADHD might affect the risk of suicide and that it increases the risk of developing additional psychiatric disorders in later life, especially if ADHD persists. This is the first long term study of its kind.

This implies that the treatment of childhood ADHD could have an important impact on later outcomes. Previous research from this group has shown that treatment of childhood ADHD can improve a number of outcomes through the age of 19. Forthcoming research should shed light on the impact of treatment on adult outcomes.

It remains to be clarified whether there is some underlying mechanism that predisposes individuals both to ADHD and other psychiatric disorders, or whether ADHD itself promotes the development of other psychiatric disorders (or both). If the latter is true, proper treatment of childhood ADHD should reduce the likelihood of developing additional psychiatric disorders.

The study population was relatively homogenous in terms of race and socioeconomic status, which limits the generalizability of the study. However, one might predict worse outcomes in settings of poverty and lack of access to treatment.

Click to read the study in Pediatrics

By Tomi Jun and Mitalee Patil

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain. 

[/tab]

[/tabs]

FDA approvedFor ADHD: Simtriyo (centanafadine), Jul 24, 2026→
Tags: ADHDsuicide
Previous Post

Carbapenem resistance in Enterobacteriaceae nearly quadrupled in the last decade, new study finds

Next Post

Lacosamide may be safe and effective supplemental anti-epileptic drug

RelatedReports

Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Second-stage cesarean and operative vaginal deliveries are associated with similar neurodevelopmental outcomes in children

February 4, 2026
Prescription medicines collage: a stone mortar and pestle, scattered white tablets and capsules, and an empty blister pack
Career Development

Tylenol in the Spotlight: Pregnancy, Autism, and Evolving Guidance on Acetaminophen use

September 25, 2025
#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder
StudyGraphics

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder

April 16, 2025
Smoking collage: an unlit cigarette, a spent match and a closed metal lighter lying on torn blue paper below a teal ribbon
Chronic Disease

Higher nicotine consumption observed among youth with attention-deficit hyperactivity disorder

May 19, 2025
Next Post
Lacosamide may be safe and effective supplemental anti-epileptic drug

Lacosamide may be safe and effective supplemental anti-epileptic drug

Low infection risk with neurologic endovascular procedures

Maternal factors increase odds of congenital vertebral malformations by 6x

Maternal factors increase odds of congenital vertebral malformations by 6x

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.